IntroductionAngiotensin converting enzyme (ACE) Angiotensin converting enzyme (ACE),' a zinc-containing dipeptidase, catalyzes the proteolytic cleavage of angiotensin I to angiotensin II (1). The generation of this physiologic pressor and vascular growth factor by ACE is believed to be of major importance in the maintenance of normal vascular tone. Angiotensin II also participates in angiogenesis (2), vascular remodeling (3), and the vascular response to injury (4). Expanding knowledge of the renin-angiotensin system suggests important roles for ACE in vascular diseases such as hypertension, atherosclerosis, and restenosis. ACE activity is widely expressed in a variety of tissues including pituitary, adrenal (5), kidney, intestine (6), heart (7), and macrophages (8). In the vasculature, ACE has been thought to be expressed predominantly on the luminal surface of the endothelial cell (9). The endothelium is believed to be the major site of angiotensin II generation from angiotensin I.The tissue renin-angiotensin system appears to be important in the vascular response to injury. Daemen (4) showed that administration of angiotensin II stimulated intimal cell proliferation. Other investigators have demonstrated that systemically administered ACE inhibitors significantly decrease intimal proliferation ( 10) or intimal mass ( 11 ) after balloon injury in the rat carotid and aorta. Although inhibition of circulating ACE may mediate this phenomenon, a large body of evidence suggests that the tissue renin-angiotensin system present in the vasculature may be more important ( 12). Vascular smooth muscle cells (VSMC) express many components of the renin-angiotensin system including angiotensinogen (13)